fAxWT

General Information


DRACP ID  DRACP05938

Peptide Name   fAxWT

Sequence  BENPESILDEHVQRVM

Sequence Length  16

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Cancer targeted peptides β-catenin inhibitor



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  β-catenin

Affinity  Kd=~5 μM

Mechanism  Inhibit wnt/β-catenin signaling pathway

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  15

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  FITC

C-terminal Modification  Amidation

Other Modification  B=β-Ala

Chiral  L



Physicochemical Information


Formula  C75H120N22O26S

Absent amino acids  ACFGKTWY

Common amino acids  E

Mass  204570

Pl  4.15

Basic residues  2

Acidic residues  4

Hydrophobic residues  4

Net charge  -2

Boman Index  -4404

Hydrophobicity  -78.13

Aliphatic Index  85

Half Life 
  /

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  2

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 23071338

Title  Inhibition of oncogenic Wnt signaling through direct targeting of β-catenin

Doi 10.1073/pnas.1208396109

Year  2012

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.